Bhanu Koppolu

Bhanu Koppolu

Auto-generated profile, based on publicly available information

Bhanu Koppolu

Immuno Oncology, Boston Scientific, Conshohocken, Pennsylvania, USA. 3

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2014 in Biomaterials
Verified
Journal Article
Closed access
BKBhanu Prasanth Koppolu
Bhanu Prasanth Koppolu
SSSean G. Smith
Sean G. Smith
SRSruthi Ravindranathan
Sruthi Ravindranathan
SJSrinivas Jayanthi
Srinivas Jayanthi
Suresh Kumar ThallapuranamSuresh Kumar Thallapuranam
Suresh Kumar Thallapuranam
DZDavid A. Zaharoff
David A. Zaharoff


5 October 2008 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
AWAniket S. Wadajkar
Aniket S. Wadajkar
BKBhanuprasanth Koppolu
Bhanuprasanth Koppolu
MRMaham Rahimi
Maham Rahimi
Kytai T. NguyenKytai T. Nguyen
Kytai T. Nguyen

1 August 2012 in Acta Biomaterialia
Verified
Journal Article
Closed access
AWAniket S. Wadajkar
Aniket S. Wadajkar
ZBZarna Bhavsar
Zarna Bhavsar
CKCheng-Yu Ko
Cheng-Yu Ko
BKBhanuprasanth Koppolu
Bhanuprasanth Koppolu
WCWeina Cui
Weina Cui
Kytai T. NguyenKytai T. Nguyen
Kytai T. Nguyen

1 April 2010 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
BKBhanuprasanth Koppolu
Bhanuprasanth Koppolu
MRMaham Rahimi
Maham Rahimi
SNSivaniarvindpriya Nattama
Sivaniarvindpriya Nattama
AWAniket Wadajkar
Aniket Wadajkar
Kytai T. NguyenKytai T. Nguyen
Kytai T. Nguyen

1 December 2012 in Journal of Biomedical Nanotechnology
Verified
Journal Article
Closed access
BKBhanuprasanth Koppolu
Bhanuprasanth Koppolu
ZBZarna Bhavsar
Zarna Bhavsar
AWAniket S. Wadajkar
Aniket S. Wadajkar
SNSivaniarvindpriya Nattama
Sivaniarvindpriya Nattama
MRMaham Rahimi
Maham Rahimi
KNKytai T. Nguyen
Kytai T. Nguyen
The objective of this work was to develop and investigate temperature-sensitive poly(N-isopropylacrylamide-acrylamide-allylamine)-coated iron oxide magnetic nanoparticles (TPMNPs) as possible targeted drug carriers for treatments of advanced thyroid cancer (ATC). These nanoparticles were prepared by free radical polymerization of monomers on the surface of silane-coupled iron oxide nanoparticles. In vitro studies demonstrated that TPMNPs were cytocompatible and effectively taken up by cancer cells in a dose-dependent manner. An external magnetic field significantly increased nanoparticle uptake, especially when cells were exposed to physiological flow conditions. Drug loading and release studies using doxorubicin confirmed the temperature-responsive release of drugs from nanoparticles. In addition, doxorubicin-loaded nanoparticles significantly killed ATC cells when compared to free doxorubicin. The in vitro results indicate that TPMNPs have potential as targeted and controlled drug carriers for thyroid cancer treatment.